These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 5068403

  • 1. Serum progesterone and serum chorionic gonadotrophin in hydatidiform mole and choriocarcinoma.
    Teoh ES, Das NP, Dawood MY, Ratnam SS.
    Acta Endocrinol (Copenh); 1972 Aug; 70(4):791-800. PubMed ID: 5068403
    [No Abstract] [Full Text] [Related]

  • 2. [HCG and SP1 in serum of patients with hydatidiform mole and chorionepithelioma--relative serum levels of both proteins in correlation to malignancy of the trophoblastic disease].
    Braun P, Leyendecker G.
    Arch Gynecol; 1979 Jul 20; 228(1-4):663-4. PubMed ID: 485549
    [No Abstract] [Full Text] [Related]

  • 3. [HCG in patients with hydatidiform mole or chorionepithelioma].
    Rjosk HK, Gokel JM, Holzmann K.
    Arch Gynecol; 1979 Jul 20; 228(1-4):667-8. PubMed ID: 485551
    [No Abstract] [Full Text] [Related]

  • 4. Quantitative chorionic gonadotrophin; prognostic value in hydatidiform mole and chorionepithelioma.
    DELFS E.
    Obstet Gynecol; 1957 Jan 20; 9(1):1-24. PubMed ID: 13388200
    [No Abstract] [Full Text] [Related]

  • 5. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N.
    Gynecol Oncol; 1982 Jun 20; 13(3):393-8. PubMed ID: 6178652
    [No Abstract] [Full Text] [Related]

  • 6. Evaluation of serum progesterone during treatment of malignant trophoblastic disease.
    Dawood MY.
    Am J Obstet Gynecol; 1975 Oct 01; 123(3):291-8. PubMed ID: 170826
    [Abstract] [Full Text] [Related]

  • 7. Progesterone concentrations in the sera of patients with intact and aborted hydatidiform moles.
    Dawood MY.
    Am J Obstet Gynecol; 1974 Aug 01; 119(7):911-8. PubMed ID: 4366792
    [No Abstract] [Full Text] [Related]

  • 8. Plasma beta-subunit human chorionic gonadotropin assay in molar pregnancy and choriocarcinoma.
    Yuen BH, Cannon W, Benedet JL, Boyes DA.
    Am J Obstet Gynecol; 1977 Apr 01; 127(7):711-2. PubMed ID: 557901
    [Abstract] [Full Text] [Related]

  • 9. [Fluctuations of plasma progesterone, 17alpha-OH-progesterone and estrogens in trophoblastic diseases (author's transl)].
    Miyamoto T.
    Nihon Naibunpi Gakkai Zasshi; 1977 Mar 20; 53(3):203-20. PubMed ID: 199477
    [No Abstract] [Full Text] [Related]

  • 10. The significance of serum progesterone and serum unconjugated oestradiol-17beta in unaborted hydatidiform mole.
    Dawood MY.
    Acta Endocrinol (Copenh); 1975 Aug 20; 79(4):729-39. PubMed ID: 169657
    [Abstract] [Full Text] [Related]

  • 11. Comparative studies on biological, immunological and biochemical properties of various human chorionic gonadotropins in blood. 1.
    Tokura T.
    Acta Obstet Gynaecol Jpn; 1970 Jul 20; 17(3):186-97. PubMed ID: 5468865
    [No Abstract] [Full Text] [Related]

  • 12. Circulating concentrations of specific placental proteins (human chorionic gonadotropin, pregnancy-specific beta-1 glycoprotein, and placental protein 5) in untreated gestational trophoblastic tumors.
    Lee JN, Salem HT, Al-Ani AT, Chard T, Huang SC, Ouyang PC, Wei PY, Seppälä M.
    Am J Obstet Gynecol; 1981 Mar 15; 139(6):702-4. PubMed ID: 6971058
    [Abstract] [Full Text] [Related]

  • 13. Pregnancy-specific beta-1-glycoprotein in trophoblastic disease.
    Rutanen EM, Seppälä M.
    J Clin Endocrinol Metab; 1980 Jan 15; 50(1):57-61. PubMed ID: 6243133
    [No Abstract] [Full Text] [Related]

  • 14. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY, Yen GL.
    Chin Med J (Engl); 1991 Dec 15; 104(12):995-8. PubMed ID: 1723674
    [Abstract] [Full Text] [Related]

  • 15. Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm.
    Jones WB, Lehr M, Lewis JL.
    Surg Forum; 1973 Dec 15; 24():563-5. PubMed ID: 4377042
    [No Abstract] [Full Text] [Related]

  • 16. The circulating alpha subunit of human chorionic gonadotrophin in gynaecologic tumours.
    Rutanen EM.
    Int J Cancer; 1978 Oct 15; 22(4):413-21. PubMed ID: 700896
    [No Abstract] [Full Text] [Related]

  • 17. [Radioimmunoassay of beta sub unit HCG following hydatidiform mole or chorionic carcinoma (author's transl)].
    Tscherne G, Pürstner P.
    Geburtshilfe Frauenheilkd; 1979 Aug 15; 39(8):704-8. PubMed ID: 478273
    [Abstract] [Full Text] [Related]

  • 18. Serum relaxin in patients with hydatidiform mole.
    Seki K, Uesato T, Tabei T, Kato K.
    Obstet Gynecol; 1986 Mar 15; 67(3):381-3. PubMed ID: 3945450
    [Abstract] [Full Text] [Related]

  • 19. Serum progesterone and serum human chorionic gonadotropin in gestational and nongestational choriocarcinoma.
    Dawood MY.
    Am J Obstet Gynecol; 1975 Dec 01; 123(7):762-5. PubMed ID: 1200070
    [Abstract] [Full Text] [Related]

  • 20. Beta-2-microglobulin in trophoblastic disease.
    Norman RJ, Jialal I, Joubert SM, Green-Thompson RW.
    S Afr Med J; 1983 Jul 16; 64(3):90-2. PubMed ID: 6191398
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.